The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.
Phase 2
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Cypher SelectDevice: Cypher
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2008-08-06
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 102
- Registration Number
- NCT00232791
- Locations
- 🇬🇧
Cardiothoracic Center Liverpool, Liverpool, United Kingdom
The Study to Assess AMI Treated With Balloon Angioplasty.
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: drug-eluting stentDevice: bare-metal stent
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2009-09-16
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 715
- Registration Number
- NCT00232830
- Locations
- 🇩🇪
University of Freiburg, Albert-Ludwigs-Universitätskliniken, Freiburg, Germany
🇫🇷HOPITAL COCHIN, René Descartes University, Paris, France
Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CYPHER Sirolimus-Eluting StentDevice: Uncoated BX VELOCITY Balloon-Expandable Stent
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2009-09-16
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 1058
- Registration Number
- NCT00232765
- Locations
- 🇺🇸
New York Presbyterian Hospital/Columbia University Medical Center, New York, New York, United States
The Study to Treat Superficial Femoral Artery Occlusions.
Phase 4
Completed
- Conditions
- Arterial Occlusive Diseases
- Interventions
- Device: stentDevice: angioplasty
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2009-06-03
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 150
- Registration Number
- NCT00232843
- Locations
- 🇬🇧
University Hospital of North Staffordshire, Newcastle under Lyme, United Kingdom
🇬🇧Manchester Royal Infirmary, Manchester, United Kingdom
The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Bx Cypher stent
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2007-10-10
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 639
- Registration Number
- NCT00232804
- Locations
- 🇫🇷
Université de Lille, Hôpital cardiologique, Lille, France
A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: drug-eluting stent
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2008-04-30
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 162
- Registration Number
- NCT00232856
- Locations
- 🇩🇪
Herz-zentrum Bad Krozingen, Bad-Krozingen, Germany
🇧🇪K.U. Leuven, Leuven, Belgium
A Multicenter Trial of Localized Radiation Therapy to Inhibit Restenosis (GAMMA V)
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2008-04-24
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 579
- Registration Number
- NCT00232778
A Study of the SMART Stent in the Treatment SFA Disease.
Phase 2
Completed
- Conditions
- Peripheral Artery Disease
- Interventions
- Device: drug-eluting stentDevice: bare-metal stent
- First Posted Date
- 2005-10-05
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 93
- Registration Number
- NCT00232869
- Locations
- 🇩🇪
University Hospital, Tübingen, Germany
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS)
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2010-04-20
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00231283
- Locations
- 🇺🇸
Texas Heart Institute, Houston, Texas, United States
Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)
Phase 3
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: CYPHER Sirolimus-Eluting Coronary Stent
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 252
- Registration Number
- NCT00231244
- Locations
- 🇺🇸
Scripps Clinic and Research, LaJolla, California, United States
© Copyright 2025. All Rights Reserved by MedPath